Skip to main content
Erschienen in: World Journal of Urology 4/2008

01.08.2008 | Original Article

Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney

verfasst von: Hakan Senturk, Sahin Kabay, Gokhan Bayramoglu, Hilmi Ozden, Faik Yaylak, Mehmet Yucel, Esra Gurlek Olgun, Ali Kutlu

Erschienen in: World Journal of Urology | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Renal ischemia/reperfusion (I/R) injury is associated with increased mortality and morbidity rates due to acute renal failure (ARF). Oxidative stress induced with renal I/R injury directly affects glomerular and tubular epithelium through reactive oxygen species. Several studies have been directed to the treatment of renal I/R injury. The aim of this study was to test the attenuation with silymarin (SM) treatment of renal I/R injury-induced morphological changes in the rat kidney.

Methods

A total of 32 adult male Sprague-Dawley rats were evaluated in four groups. Group I (sham), Group II (renal I/R), Group III (renal I/R injury + SM 50 mg per kg) and Group IV (renal I/R injury + SM 100 mg per kg) were designed to evaluate the dose-dependent effects of SM on the morphological changes of renal I/R injury. Renal I/R injury were induced with left renal pedicle occlusion for 45 min followed with reperfusion for 6 h under anesthesia. After induction of I/R injury, left nephrectomies were performed for histopathological examinations.

Results

After renal I/R injury, significant tubular dilatation, tubular vacuolization, pelvic inflammation, interstitial inflammation, perirenal adipose infiltration, tubular necrosis and glomerular necrosis (cortical necrosis) were observed. However, even with low dose SM in Group III (50 mg per kg SM), histopathological changes due to I/R injury were prevented.

Conclusions

The results of this study have demonstrated that SM significantly prevents renal I/R injury-induced renal tubular changes in the rat. SM in 50 mg/kg was observed to be sufficient to significantly prevent renal tubular necrosis. Further, to our literature knowledge, this is the first specific study to demonstrate the preventive effect of SM on renal I/R injury.
Literatur
1.
Zurück zum Zitat Avlan D, Tamer L, Ayaz L, Polat A, Ozturk C, Ozturhan H, Camdeviren H, Aksoyek S (2006) Effects of trapidil on renal ischemia–reperfusion injury. J Pediatric Surg 41:1686–1693CrossRef Avlan D, Tamer L, Ayaz L, Polat A, Ozturk C, Ozturhan H, Camdeviren H, Aksoyek S (2006) Effects of trapidil on renal ischemia–reperfusion injury. J Pediatric Surg 41:1686–1693CrossRef
2.
3.
Zurück zum Zitat Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489–1494PubMedCrossRef Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489–1494PubMedCrossRef
4.
Zurück zum Zitat Rodrigo R, Bosco C (2006) Oxidative stress and protective effects of polyphenols: Comparative studies in human and rodent kidney. A review. Comp Biochem Physiol 142:317–327 Rodrigo R, Bosco C (2006) Oxidative stress and protective effects of polyphenols: Comparative studies in human and rodent kidney. A review. Comp Biochem Physiol 142:317–327
5.
Zurück zum Zitat Thurman JM (2007) Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 123:7–13PubMedCrossRef Thurman JM (2007) Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 123:7–13PubMedCrossRef
6.
Zurück zum Zitat Sener G, Tugtepe H, Yuksel M, Cetinel S, Gedik N, Yegen BC (2006) Resveratrol improves ischemia/reperfusion-induced oxidative renal injury in rats. Arch Med Res 37:822–829PubMedCrossRef Sener G, Tugtepe H, Yuksel M, Cetinel S, Gedik N, Yegen BC (2006) Resveratrol improves ischemia/reperfusion-induced oxidative renal injury in rats. Arch Med Res 37:822–829PubMedCrossRef
7.
Zurück zum Zitat Gobe G, Johnson DW (2007) Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 39: 1551–1561PubMedCrossRef Gobe G, Johnson DW (2007) Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 39: 1551–1561PubMedCrossRef
8.
Zurück zum Zitat Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141–1148PubMedCrossRef Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141–1148PubMedCrossRef
9.
Zurück zum Zitat Mora A, Paya M, Rios J, Alcaraz M (1990) Structure activity relationships of polymetoxyflavones and other flavonoids as inhibitors of non-enzymatic lipid peroxidation. Biochem Pharmacol 40:793–794PubMedCrossRef Mora A, Paya M, Rios J, Alcaraz M (1990) Structure activity relationships of polymetoxyflavones and other flavonoids as inhibitors of non-enzymatic lipid peroxidation. Biochem Pharmacol 40:793–794PubMedCrossRef
10.
Zurück zum Zitat Zhao B (2005) Natural antioxidants for neurodegenerative diseases. Mol Neurobiol 31:283–294PubMedCrossRef Zhao B (2005) Natural antioxidants for neurodegenerative diseases. Mol Neurobiol 31:283–294PubMedCrossRef
11.
Zurück zum Zitat Karimi G, Ramezani M, Tahoonian Z (2005) Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid Based Complement Alternat Med 2:383–386PubMedCrossRef Karimi G, Ramezani M, Tahoonian Z (2005) Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid Based Complement Alternat Med 2:383–386PubMedCrossRef
12.
Zurück zum Zitat Marubayashi S, Dohi K (1996) Therapeutic modulation of free radical-mediated reperfusion injury of the liver and its surgical implications. Surg Today 26:573–580PubMedCrossRef Marubayashi S, Dohi K (1996) Therapeutic modulation of free radical-mediated reperfusion injury of the liver and its surgical implications. Surg Today 26:573–580PubMedCrossRef
13.
Zurück zum Zitat Granger DN, Korthuis RJ (1995) Physiological mechanisms of postischemic tissue injury. Annu Rev Physiol 57:311–332PubMed Granger DN, Korthuis RJ (1995) Physiological mechanisms of postischemic tissue injury. Annu Rev Physiol 57:311–332PubMed
14.
Zurück zum Zitat Zimmerman BJ, Grisham MB, Granger DN (1990) Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 258:G185–G190PubMed Zimmerman BJ, Grisham MB, Granger DN (1990) Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 258:G185–G190PubMed
15.
Zurück zum Zitat Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR (1999) Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia–reperfusion. Am J Physiol 277:R922–R929PubMed Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR (1999) Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia–reperfusion. Am J Physiol 277:R922–R929PubMed
16.
Zurück zum Zitat Weight SC, Bell PR, Nicholson ML (1996) Renal ischemia–reperfusion injury. Br J Surg 83:162–170PubMedCrossRef Weight SC, Bell PR, Nicholson ML (1996) Renal ischemia–reperfusion injury. Br J Surg 83:162–170PubMedCrossRef
17.
Zurück zum Zitat Willams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R (1997) Characterization of renal ischemia–reperfusion injury in rats. J Pharmacol Toxicol Methods 37:1–7CrossRef Willams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R (1997) Characterization of renal ischemia–reperfusion injury in rats. J Pharmacol Toxicol Methods 37:1–7CrossRef
18.
Zurück zum Zitat Molitoris BA, Mars J (1999) The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106:583–592PubMedCrossRef Molitoris BA, Mars J (1999) The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106:583–592PubMedCrossRef
19.
Zurück zum Zitat Huang W, Lee SL, Sjöquist M (1995) Natriuretic role of endogenous oxytocin in male rats infused with hypertonic NaCl. Am J Physiol 268:R634–R640PubMed Huang W, Lee SL, Sjöquist M (1995) Natriuretic role of endogenous oxytocin in male rats infused with hypertonic NaCl. Am J Physiol 268:R634–R640PubMed
20.
Zurück zum Zitat Sehirli AO, Sener G, Satiroglu H, Ayanoglu-Dulger G (2003) Protective effect of N-acetylcysteine on the renal ischemia/reperfusion injury in the rat. J Nephrol 16:75–80PubMed Sehirli AO, Sener G, Satiroglu H, Ayanoglu-Dulger G (2003) Protective effect of N-acetylcysteine on the renal ischemia/reperfusion injury in the rat. J Nephrol 16:75–80PubMed
21.
Zurück zum Zitat Sener G, Sehirli O, Erkanli G, Cetinel S, Gedik N, Yegen BC (2004) 2-mercaptoethane sulfonate (MESNA) protects against burn-induced renal injury in rats. Burns 30:557–564PubMedCrossRef Sener G, Sehirli O, Erkanli G, Cetinel S, Gedik N, Yegen BC (2004) 2-mercaptoethane sulfonate (MESNA) protects against burn-induced renal injury in rats. Burns 30:557–564PubMedCrossRef
22.
Zurück zum Zitat Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9:105–113PubMedCrossRef Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9:105–113PubMedCrossRef
23.
Zurück zum Zitat Luper S (1998) A review of plants used in the treatment of liver disease: part 1. Alternat Med Rev 3:410–421 Luper S (1998) A review of plants used in the treatment of liver disease: part 1. Alternat Med Rev 3:410–421
24.
Zurück zum Zitat Chang JW, Kim CS, Kim SB, Park SK, Park JS, Lee SK (2006) Proinflammatory cytokine-induced NF-kappaB activation in human mesangial cells is mediated through intracellular calcium but not ROS: effects of silymarin. Nephron Exp Nephrol 103:e156–e165PubMedCrossRef Chang JW, Kim CS, Kim SB, Park SK, Park JS, Lee SK (2006) Proinflammatory cytokine-induced NF-kappaB activation in human mesangial cells is mediated through intracellular calcium but not ROS: effects of silymarin. Nephron Exp Nephrol 103:e156–e165PubMedCrossRef
25.
Zurück zum Zitat Kren V, Walterova D (2005) Silybin and silymarin—new effects and applications. Biomed Papers 149:29–41 Kren V, Walterova D (2005) Silybin and silymarin—new effects and applications. Biomed Papers 149:29–41
26.
Zurück zum Zitat Sonnenbichler J, Zetl I (1986) Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog Clin Biol Res 213:319–331PubMed Sonnenbichler J, Zetl I (1986) Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog Clin Biol Res 213:319–331PubMed
27.
Zurück zum Zitat Moscarell S, Giusti A, Marra F, Marena C, Lampertico M, Relli P, Gentilini P, Buzzelli G (1993) Therapeutic and antilipoperoxidant effects of silybin phophatidylcholine complex in chronic liver disease: preliminary results. Curr Therapeut Res 53:1CrossRef Moscarell S, Giusti A, Marra F, Marena C, Lampertico M, Relli P, Gentilini P, Buzzelli G (1993) Therapeutic and antilipoperoxidant effects of silybin phophatidylcholine complex in chronic liver disease: preliminary results. Curr Therapeut Res 53:1CrossRef
28.
Zurück zum Zitat Farghali H, Kameniková L, Hynie S, Kmonicková E (2000) Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 41:231–237PubMedCrossRef Farghali H, Kameniková L, Hynie S, Kmonicková E (2000) Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 41:231–237PubMedCrossRef
29.
Zurück zum Zitat Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA (2002) Milk thistle for the treatment of liver disease: a systemic review and meta-analysis. Am J Med 113:506–515PubMedCrossRef Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA (2002) Milk thistle for the treatment of liver disease: a systemic review and meta-analysis. Am J Med 113:506–515PubMedCrossRef
Metadaten
Titel
Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney
verfasst von
Hakan Senturk
Sahin Kabay
Gokhan Bayramoglu
Hilmi Ozden
Faik Yaylak
Mehmet Yucel
Esra Gurlek Olgun
Ali Kutlu
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 4/2008
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-008-0256-1

Weitere Artikel der Ausgabe 4/2008

World Journal of Urology 4/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.